STAT+: Medicare Is Spending Far Less than Expected on New Alzheimer’s Drugs
Medicare’s uptake of the newly approved Alzheimer’s therapies Leqembi and Kisunla is far lower than projected, prompting the agency to forecast minimal spending through 2026‑2027. Earlier estimates had anticipated billions in annual costs, but real‑world adoption has stalled. The drugs require intravenous infusions and extensive brain imaging, limiting patient access. Moreover, clinicians report modest cognitive benefits alongside serious risks such as brain hemorrhage, further dampening demand.
STAT+: Five Years After Disaster, a Rare Disease Community Gets New Chance at Treatment
Astellas Pharma has re‑initiated its gene‑therapy trial for X‑linked myotubular myopathy (XLMTM) five years after a previous study was halted by safety concerns. Early observations from the first participant, Joshua "JJ" Gonzalez, indicate a dramatic reduction in airway suctioning, suggesting...
Henlius Receives US FDA IND Clearance for HLX05-N (Biosimilar, Erbitux)
Henlius announced that the U.S. Food and Drug Administration granted Investigational New Drug (IND) clearance for HLX05‑N, its biosimilar version of Erbitux (cetuximab), aimed at treating metastatic colorectal cancer. The IND follows extensive analytical and non‑clinical studies that demonstrated high...
Across the Nutraverse: Chemist Warehouse to Enter the UK, H&B Partners with Phlo, NutraIngredients Europe Awards
Australian discount pharmacy giant Chemist Warehouse is entering the UK through a joint venture with London‑based GreenLight, converting up to five stores to its low‑margin, high‑volume format. The deal gives Sigma Healthcare a 75% stake, leveraging its recent merger with...
Nuclera Launches Antibody Triage Service to Advance AI-Driven Antibody Discovery
Nuclera, a biotech firm specializing in protein production, announced a new antibody‑screening service designed to accelerate AI‑driven antibody discovery. The offering uses a 96‑plex cell‑free expression platform and surface plasmon resonance to triage large in‑silico‑generated libraries, delivering early binding data...
Eliminating Manual Data Entry: How Automation Empowers Care Teams And Improves Outcomes
Healthcare providers are turning to AI‑driven automation to replace manual data entry and create a unified, cleansed patient record—often called a single version of the truth. By aggregating data from hospitals, labs, and patients, the system delivers real‑time, actionable summaries...
Kori Lands Latest Deal for Care UK
Kori Construction has secured its fourth partnership with Care UK, launching a new £12 million (≈$15 million) three‑storey care facility in Mitcham. Demolition of the existing building begins this week, paving the way for specialist residential, nursing and dementia accommodation. The development...
My First Thought After Having a Vasectomy: Why Aren’t More British Men Having Them? | Tim Burrows
Tim Burrows describes his own vasectomy after a two‑year NHS wait, noting the procedure is quick and low‑risk. UK vasectomy numbers have dropped 62% from 30,400 in 2004‑05 to 10,880 in 2015‑16, with men accounting for only 5.3% of contraceptive‑service...
Root Causes | Are Employers Doing Enough to Support Staff Through Britain's Dental Care Crisis?
UK workers face a mounting dental care crisis as NHS capacity dwindles. Recent British Dental Association data show 96.9% of patients without a dentist failed to secure NHS appointments, leaving many to wait months or turn to costly private care....
MDT-Based Comprehensive Management of Type 3 Von Willebrand Disease in Pregnancy: From Preimplantation Genetic Testing to Antenatal Care, Delivery and...
Researchers reported the first use of recombinant von Willebrand factor (rVWF) in China to manage a pregnancy complicated by type 3 von Willebrand disease. A 36‑year‑old patient conceived via IVF and received target‑guided rVWF dosing before amniocentesis and elective caesarean, achieving activity...
BMS’ Sotyktu (Deucravacitinib) Wins EC Approval to Treat Adults with Active Psoriatic Arthritis (PsA)
The European Commission has approved Bristol‑Myers‑Squibb’s oral drug Sotyktu (deucravacitinib) for adults with active psoriatic arthritis, either alone or with methotrexate. The decision follows positive Phase III data from the POETYK PsA‑1 and POETYK PsA‑2 trials, which enrolled over 1,200 patients and met...
Patient Perspectives on Gene Therapies and Gene Editing for Familial Cardiomyopathies
Early‑phase trials are testing gene replacement and editing for hypertrophic and dilated cardiomyopathies, yet patient viewpoints remain understudied. Interviews with 21 adults (average age 57, 57% female) revealed four decision drivers: perceived disease severity, quality‑of‑life impact, treatment safety and delivery,...
'We Have to Respond to Women's Health Needs More Easily'
Liverpool’s health review shows women spend about 30% of their lives in poor health and die roughly ten years earlier than the national average. The report also found lung‑cancer mortality double and drug‑related deaths more than three times the England...
Advances in RSV Vaccine Research and Development
Respiratory syncytial virus (RSV) remains a leading cause of acute lower‑respiratory infections, accounting for roughly 33 million cases and over 3 million hospitalizations each year, especially in children under five and older adults. Recent advances focus on stabilizing the prefusion F (preF)...
What Is Frozen Shoulder? And Will I Need Surgery?
Frozen shoulder, or adhesive capsulitis, affects about 8 % of men and 10 % of women aged 25‑64, with prevalence rising sharply after age 40. The condition progresses through three stages—freezing, frozen, and thawing—and can linger for months or years, often leaving residual...
Hong Kong Outlines Strategy to Strengthen Global Health Innovation and Clinical Trials
Hong Kong announced a comprehensive strategy to become a regional hub for health innovation, focusing on expanding clinical trial capacity, regulatory reform, and research commercialization. The government unveiled the Greater Bay Area International Clinical Trial Institute, a “one institute, one...
Molina Healthcare, Inc. (MOH) Analyst/Investor Day Transcript
Molina Healthcare hosted its 2026 Analyst/Investor Day on May 11, 2026, featuring presentations by CEO Joseph Zubretsky, CFO Mark Keim and COO James Edwin Woys. The event highlighted the company’s strategic focus on expanding Medicaid enrollment and improving operational efficiency. Financial leadership...
Published FDA Rejections Point to Manufacturing, Data Gaps as Key Stumbling Blocks
The FDA’s new policy to publish complete response letters (CRLs) has made over 350 rejection letters publicly available, revealing that more than half of drug rejections stem from manufacturing problems and 41% from product‑quality issues. Analysts say the transparency lets...
Report: Kentucky’s Overdose Deaths Keep Falling
Kentucky’s opioid death toll, which peaked at 2,257 in 2021, has fallen to 1,178 total deaths in 2025, including 1,100 residents, marking four consecutive years of decline. The drop follows a 30% reduction from 2023 to 2024 and a further...
This 800-Year-Old Chinese Exercise Helps Lower Blood Pressure Naturally
A large multicenter randomized trial published in JACC found that practicing baduanjin, an 800‑year‑old Chinese exercise, lowered systolic blood pressure as effectively as brisk walking. Over 216 adults with stage 1 hypertension performed the 10‑15‑minute routine five days a week, achieving...
BeOne Medicines Recognized as "Outstanding Global Oncology Company of the Year" At HKCT Business Awards 2026
BeOne Medicines was named "Outstanding Global Oncology Company of the Year" at the 2026 HKCT Business Awards, recognizing its rapid R&D progress and manufacturing capabilities. The Swiss‑based firm now operates in more than 45 markets, employs over 1,200 oncology R&D...
Hong Kong Highlights Innovation and Greater Bay Area Collaboration at Hospital Authority Convention 2026
Hong Kong officials used the Hospital Authority Convention 2026 to unveil a suite of health‑innovation policies, including faster drug approvals, a new regulatory centre, and expanded AI use in hospitals. A Greater Bay Area Clinical Trial Collaboration Platform will allow...
Maintaining Trust in Medical AI: Monitoring and Managing Model Lifecycle
Artificial intelligence is becoming integral to health‑tech, powering diagnostics, decision support and patient management. However, models trained on historic data can lose accuracy as patient populations, clinical practices and data capture evolve. The article explains data drift (shifts in input...
ElITE 2026 – CHANGE MANAGEMENT CHAMPION – Amy Atwood
Amy Atwood, head of transformation and change management at Real Chemistry’s RC Resolve, brings three decades of experience guiding complex organizational change in healthcare and other sectors. Her people‑first methodology blends strategic discipline with behavioral insight, ensuring transformation initiatives are...
Heron Therapeutics Inc (HRTX) Q1 2026 Earnings Call Transcript
Heron Therapeutics reported $155 million in 2025 net product revenue and adjusted EBITDA of $14.7 million, surpassing its guidance range. Acute‑care sales surged, with ZYNRELEF revenue up 48% YoY and the franchise growing 57% in Q4, driven by the CrossLink IGNITE program, a...
Liquidia Corp (LQDA) Q1 2026 Earnings Call Transcript
Liquidia Corp reported $148.3 million full‑year net product sales, with $90.1 million generated in Q4 and a 74% quarter‑over‑quarter increase. The company achieved its second consecutive profitable quarter, posting $27.3 million adjusted EBITDA and $14.6 million net income, while generating $33 million of operating cash...
Predicting the Geographical Distribution of Drug Use Disorder in Sweden From the Geographical Variation in Social Deprivation, Genetic Risk and...
A new Swedish study used geographically weighted regression across 5,983 DeSO areas to dissect the spatial variation of drug use disorder (DUD). The analysis found that family‑genetic risk scores (FGRS) explain roughly 58% of the variance, while social deprivation accounts...
Exagen Inc (XGN) Q1 2026 Earnings Call Transcript
Exagen reported Q1 2022 revenue of $10.4 million, driven by a record 30,903 AVISE CTD/Lupus tests and 2,175 ordering providers. The company secured a new Medicare PLA code (0312U) for AVISE Lupus, boosting reimbursement from $295 to $1,085 per test. Gross...
EMVision Expands Pivotal FDA Trial to Include Acute Ischaemia Detection
EMVision Medical Devices has expanded its pivotal FDA De Novo trial to evaluate acute ischaemia detection alongside its original haemorrhage indication. The trial now includes over 125 recruited patients with no reported device‑related adverse events, and full enrollment is projected...
NHS Bank Staff ‘at Least as Expensive’ as Using Agency Workers
Freedom of information data reveal that several NHS trusts are paying bank‑staff shifts at rates higher than agency staff, contradicting the Department of Health’s claim that bank staffing saves taxpayers money. At Nottingham University Hospitals, the five costliest bank shifts...
Pooled Analysis Reveals Semaglutide Shows Good Efficacy in Older Adults Aged over 65 Years
A pooled analysis of Novo Nordisk's STEP trials examined semaglutide 2.4 mg in adults over 65 with obesity. The senior subgroup (n=358) lost an average of 15.4% of body weight over 68 weeks, compared with 5.1% on placebo, and showed marked...
Could the 'Ozempic Era' Shift Blame for Obesity From Individuals to the Food Industry?
An essay presented at the European Congress on Obesity argues that the surge of GLP‑1 agonist drugs, such as Ozempic, could reframe obesity from an individual failing to a systemic problem driven by the commercial food industry. The authors cite...
:max_bytes(150000):strip_icc():format(jpeg)/what-medications-are-used-to-treat-binge-eating-5203479-notext-FINAL-23d015661f974a32b31410418e25c630.png)
What Medications Are Used to Treat Binge Eating?
Vyvanse (lisdexamfetamine) remains the sole FDA‑approved medication for binge‑eating disorder, a condition affecting millions of Americans and linked to serious health complications. Cognitive‑behavioral therapy (CBT) is the primary non‑pharmacologic treatment and consistently reduces binge episodes, though it does not guarantee...
:max_bytes(150000):strip_icc():format(jpeg)/potential-side-effects-of-cbd-5072819-Color-4c956576aea84aa093fde1b1b10ce31c.png)
The Potential Side Effects of CBD
Cannabidiol (CBD) is booming in consumer markets, but users should be aware of its common side effects such as drowsiness, dry mouth, and gastrointestinal upset. Clinical data show CBD can elevate liver enzymes, signaling possible liver injury, especially at higher...
Australia Has the World's Highest Rate of ACL Reconstruction Surgery—Rehab May Be Just as Good
Australia records the world’s highest rate of anterior cruciate ligament (ACL) reconstruction, with roughly 90% of active adults choosing surgery. Recent international evidence shows that structured, exercise‑based rehabilitation can achieve comparable strength, functional, and sport‑return outcomes to immediate surgery. About...
Visiting Medical Officers’ $1.3bn Pay Excoriated by NSW Auditor-General
The NSW auditor‑general released a scathing report on the state Health Department’s management of visiting medical officers (VMOs), highlighting $1.3 bn in payments with little oversight. The audit uncovered systemic failures in risk management, remuneration controls, and IT systems that support...
Doctors Can Act as Gatekeepers or Brokers for Patients – How They Decide Can Be Crucial
New research shows that general practitioners and hospital doctors can function either as gatekeepers, limiting unnecessary tests, or as brokers, actively securing scarce resources for patients with terminal cancer. When acting as gatekeepers, doctors sometimes delay referrals, leading to later...
Why Did My Baby Die? I’m a Pathologist. Here’s What I Want You to Know
In Australia roughly six babies are stillborn each day, and for one‑third of those cases the cause remains unknown because investigations are incomplete. Perinatal pathologists examine the placenta first, then may perform a full or limited autopsy to uncover medical...
Not Just Insulin: Early Increases in Glucagon in Type 2 Diabetes Are Linked to Fatty Liver Disease
A German Diabetes Center study of 50 newly diagnosed type 2 diabetes patients and 50 controls found post‑meal glucagon levels about 75% higher within the first year of diagnosis. The surge was tightly linked to liver fat content rather than classic...
Why So Many Doctors Are Walking Away Before Age 50
A 2024 AMA‑backed survey published in The Permanente Journal shows U.S. physicians are exiting clinical practice at a mean age of 48.1 years—nine years earlier than the 57.1‑year average in 2008. The study found 11 percent of residency‑trained doctors quit before...
Gallium‐Containing Agents for Tumor Diagnosis and Therapy: Current Status and Future Prospects
Gallium-based agents are emerging as powerful tools in tumor theranostics, combining diagnostic precision with therapeutic action. 68Ga-labeled PET probes have become routine for detecting prostate, neuroendocrine and other cancers, while gallium therapeutics target DNA metabolism, tumor immunity and angiogenesis. The...
Field‑Programmable Biofunctional Films: From Assisted Fabrication to Integrated Diagnostic‐Therapeutic Devices
Field‑programmable biofunctional films (FPBFs) are thin‑film platforms that can be programmed to react to a range of physical fields—thermal, mechanical, electrical, optical, magnetic and acoustic. Recent advances in single‑ and multi‑field‑assisted fabrication have expanded their structural tunability and functional density,...
National Ambulance Service to Be ‘Significantly Impacted’ by Industrial Action on Monday
The Health Service Executive (HSE) warned that Ireland’s National Ambulance Service will be "significantly impacted" after about 2,000 SIPTU and Unite members begin a work‑to‑rule at 8 a.m. Monday, followed by a 24‑hour strike later that night. Emergency cover has been...
Was Mount Sinai’s Victory in a Dispute Over a Physician’s Credentialing Worth It?
Mount Sinai South Nassau adopted new medical staff bylaws in June 2025 that tighten board‑certification requirements, effectively disqualifying Dr. Nakul Karkare’s Indian board certification despite his prior privileges dating back to 2018. The hospital offered him resignation or an appeal, warning...
With Commissioner Under Pressure, F.D.A. Opens Door to Flavored Vapes
The Trump administration released an FDA guidance that would permit flavored e‑cigarettes to be sold in mainstream retail outlets, effectively rolling back a year of tightened tobacco‑control measures. The move comes amid reports that President Trump signed a plan to...
Conn. Firefighter with End-Stage Kidney Failure Finds Donor Match
Derby, Conn., volunteer firefighter Chris “CJ” Matto, 33, was recently matched with a kidney donor after being diagnosed with end‑stage kidney disease. The Shelton Fire Department announced the match and a June 6 car‑wash fundraiser to offset medical expenses for Matto...
W.Va. Congresswoman Honored for Rural EMS Advocacy
U.S. Rep. Carol Miller was honored as one of the American Ambulance Association’s Person of the Year for her advocacy on rural emergency medical services. The award highlights her work on ambulance reimbursement, treatment‑in‑place payment models, and the PEAKS Act,...
Mental Illness Is Pregnancy’s No 1 Complication. It’s Time to Support Those Who Suffer From It | Edna Lekgabe
Perinatal mental illness affects roughly one in five women from conception through the first year after birth, making it the most common complication of pregnancy. Despite its prevalence, systematic screening and treatment pathways lag behind those for physical conditions such...
Evaluating the Effectiveness and Safety of Digitalis Glycosides in Treating Heart Failure
A JAMA‑published trial presented at the ESC Heart Failure 2026 Congress found that adding digitalis glycosides to standard therapy lowered the combined risk of cardiovascular death and first worsening heart‑failure event in patients with HFmrEF and HFrEF. The reduction was...